Dr Agarwal’s Health Care Limited is coming up with an IPO consisting of a fresh issue of shares worth INR 300 crores and an offer to sell 6.96 existing shares. The company aims to repay borrowings and utilise funds for corporate purposes.
Dr Agarwal’s Health Care IPO – Important Dates
Dr Agarwal’s Health Care Limited IPO Date | January 29, 2025 to January 31, 2025 |
Dr Agarwal’s Health Care Limited IPO Listing Date | February 5, 2025 |
Dr Agarwal’s Health Care Limited IPO Price | INR 382 – 402 per share |
Dr Agarwal’s Health Care Limited IPO Lot Size | 35 Shares |
Dr Agarwal’s Health Care Limited IPO Total Issue Size | 3,027.26 Crore |
Dr Agarwal’s Health Care Limited IPO Basis of Allotment | February 3, 2025 |
Dr Agarwal’s Health Care Limited IPO Initiation of Refunds | February 4, 2025 |
Dr Agarwal’s Health Care Limited IPO Credit of Shares to Demat | February 4, 2025 |
Dr Agarwal’s Health Care Limited IPO Issue Type | Book Built Issue IPO |
Dr Agarwal’s Health Care Limited IPO Listing At | BSE NSE |
Dr Agarwal’s Health Care Limited IPO – Company Profile
Dr. Agarwal’s Health Care Limited offers comprehensive eye care services, including cataract, refractive, and other surgeries, consultations, diagnostics, non-surgical treatments, and products like opticals, contact lenses, accessories, and eye care pharmaceuticals.
With a hub-and-spoke model, Dr Agarwal’s Health Care Limited operates 26 tertiary facilities, 139 spokes, and three centres of excellence, providing scalable and accessible eye care services, from diagnosis to specialised surgeries across India.
Since 2012, Dr Agarwal’s Health Care Limited has expanded internationally, operating 15 facilities across nine African countries, offering cataract, glaucoma, diabetic retinopathy treatments, refractive surgeries, and pediatric and neuro-ophthalmological services.
Dr Agarwal’s Health Care Ltd IPO Fundamental Analysis
Dr Agarwal’s Health Care Limited’s financial analysis reveals a mixed performance. Revenue has shown consistent growth, while equity and liabilities reflect expansion. Profitability and earnings per share have increased, though the return on net worth has decreased.
- Revenue Trend: The revenue increased from ₹6,960.78 millions in March 2022 to ₹10,179.80 millions in March 2023. The revenue for the current year’s 12-month period ending March 2024 is INR 13,321.52 million.
- Equity and Liabilities: Equities and liabilities have shown a consistent increase over the periods, reflecting potential growth and expansion. However, the debt-equity ratio has decreased, indicating reduced reliance on debt financing
- Profitability: The profit after tax (PAT) has significantly increased from ₹431.64 million in March 2022 to ₹950.51 million by March 2024. This improvement in profitability could be a source of confidence among investors.
- Earnings per Share (EPS): The diluted EPS has risen from ₹1.83 in March 2022 to ₹3.13 by March 2024, reflecting higher earnings per share for investors.
- Return on Net Worth (RoNW): The RoNW has decreased from 17.75% to 6.21%, indicating a decrease in the company’s ability to generate returns on shareholder equity.
- Financial Position: Total assets have increased, suggesting potential business growth. However, the current ratio has increased, indicating strengthening liquidity and potential challenges in meeting short-term obligations.
- Inventory Turnover Ratio: There’s a significant increase in the Inventory Turnover Ratio, which might suggest faster sales or efficient inventory management.
Dr Agarwal’s Health Care IPO Financial Analysis
Particular | As of 31 March 2022 | As of 31 March 2023 | As of 31 March 2024 |
Revenue (₹ in millions) | 6,960.78 | 10,179.80 | 13,321.52 |
Equity (₹ in millions) | 2,338.21 | 6,590.71 | 13,795.11 |
Expenses (₹ in millions) | 6,570.21 | 9,479.03 | 12,358.81 |
Profit and Loss After Tax (₹ in millions) | 431.64 | 1,032.30 | 950.51 |
Diluted EPS only (₹) | 1.83 | 4.00 | 3.13 |
Return on Net Worth (%) | 17.75 | 14.99 | 6.21 |
NAV per Equity Share (₹) | 10.32 | 26.73 | 50.53 |
Total Assets (in millions) | 10,261.34 | 18,251.74 | 27,528.16 |
Total Liabilities (₹ in millions) | 7,923.13 | 11,661.03 | 13,733.05 |
Debt-Equity Ratio | 2.71 | 1.30 | 0.70 |
Current Ratio (in times) | 1.10 | 1.03 | 1.90 |
Inventory Turnover Ratio | 5.23 | 6.78 | 6.85 |
Dr Agarwal’s Health Care Limited IPO Peer Comparison
Dr. Agarwal’s Health Care Limited has demonstrated strong revenue growth, outperforming competitors like Apollo Hospitals, Max Healthcare, and Fortis Healthcare in terms of profitability, return on equity, and earnings per share.
Company | Revenue from Operations (₹ in millions) | Face Value per Equity Share (₹) | P/E Ratio | EPS (Basic) (₹) | EPS (Diluted) (₹) | RoNW (%) | NAV (₹ in millions) |
Dr. Agarwal’s Health CareLimited | 13,321.52 | 1 | – | 3.14 | 3.13 | 6.21 | 50.53 |
Apollo Hospitals Enterprise Limited | 190,592.00 | 5 | 113.47 | 62.50 | 62.50 | 12.97 | 481.93 |
Max Healthcare Institute Limited | 68,490.00 | 10 | 98.56 | 10.89 | 10.84 | 12.58 | 86.54 |
Fortis Healthcare Limited | 68,929.20 | 10 | 76.33 | 7.93 | 7.93 | 7.82 | 101.48 |
Global Health Limited | 32,751.11 | 2 | 62.32 | 17.80 | 17.80 | 16.46 | 108.17 |
Narayana Hrudayalaya Limited | 50,182.49 | 10 | 32.04 | 38.86 | 38.86 | 27.37 | 141.98 |
Krishna Institute Of Medical Sciences Limited | 24,981.44 | 10 | 14.13 | 38.75 | 38.75 | 16.96 | 228.47 |
Aster DM Healthcare Limited | 36,989.00 | 10 | 162.10 | 2.60 | 2.60 | 3.63 | 71.62 |
Rainbow Children’s Medicare Limited | 12,969.00 | 10 | 64.46 | 21.38 | 21.38 | 17.24 | 124.03 |
Dr Agarwal’s Health Care Ltd IPO Objective
The main objective of Dr Agarwal’s Health Care Limited is to repay/prepay, in part or whole, specific to their borrowings.
- Repayment/ prepayment, in part or whole, of certain of their borrowings: The company intends to utilise INR 195 crores from the net proceeds for repayment/prepayment of borrowings, reducing indebtedness, enhancing the debt-equity ratio, and supporting future business growth and expansion opportunities.
- General corporate purposes: The company will deploy funds for general corporate purposes, including fixed assets, short-term working capital requirements, IT infrastructure, distribution network, rental and administrative expenses, and meeting exigencies and other operational costs.
Dr Agarwal’s Health Care IPO Risks And Challenges
Dr Agarwal’s Health Care Limited’s risk includes potential declines in surgery revenue due to factors like patient footfall, doctor attrition, economic conditions, and reputational damage, alongside challenges in maintaining brand strength, service quality, and staffing.
- The company generates significant revenue from surgeries, which may decline due to reduced patient footfall, reputational harm, doctor attrition, economic conditions, or medical innovations, potentially impacting business, financial conditions, and operations.
- The company’s brand and reputation, crucial for success, may be affected by factors like service quality, technology adoption, medical malpractice, or adverse publicity, which could impact business, financial condition, and future growth.
- The company’s success relies on recruiting and retaining skilled doctors and medical staff. Challenges like doctor turnover, competition, and potential conflicts of interest may impact service quality, patient volumes, and business performance.
Dr Agarwal’s Health Care Ltd IPO – Industry & Market Potential
The healthcare delivery market in India is expected to grow at 9-11% CAGR, reaching ₹9.1-9.3 trillion by FY 2028, driven by lifestyle ailments, medical tourism, rising incomes, and increasing private sector involvement in healthcare services.
The Indian eye care industry, projected to grow at 12-14% CAGR to ₹550-650 billion by 2028, is driven by the high prevalence of vision disorders. Key factors include qualified staff, experienced ophthalmologists, and a patient-focused approach.
The Indian eye pharma market, growing at 7-9% CAGR, reached ₹33-38 billion in FY 2024. Key factors include rising income, increasing eye disorders, ageing population, lifestyle changes, and health insurance penetration, projected to reach ₹46-51 billion by FY 2028.
Dr Agarwal’s Health Care Limited IPO – Type of Offer
Dr Agarwal’s Health Care Limited plans a fresh issue of shares, seeking INR 300 crores to repay borrowings and utilise funds for corporate purposes. Additionally, the company proposes an offer to sell 6.96 crore existing shares.
- Fresh Issue: The company will issue new shares to raise capital, aiming to collect INR 300 crores. The company intends to utilise the proceeds from the fresh issue to repay borrowings and utilise funds for corporate purposes.
- Offer for sale: Dr Agarwal’s Health Care Limited is offering to sell 6.96 crore existing shares. The following are the details of the existing shareholders who are also the promoters selling the shares:
Name of the promoter selling shareholder | No. of shares offered |
Dr. Amar Agarwal | 2,253,913 |
Dr. Athiya Agarwal | 2,704,696 |
Dr. Adil Agarwal | 2,961,614 |
Dr. Anosh Agarwal | 5,242,630 |
Dr. Ashvin Agarwal | 230,035 |
Dr. Agarwal’s Eye Institute | 1,963,172 |
Dr Agarwal’s Health Care IPO Offer Size
The offer size of Dr Agarwal’s Health Care Limited is yet to be announced, consisting of a fresh issue of shares worth INR 300 crores and an offer to sell 6.96 existing shares. The company aims to repay borrowings and utilise funds for corporate purposes.
Dr Agarwal’s Health Care Limited IPO Allotment Structure
Dr Agarwal’s Health Care Limited’s allocation will be as follows: 50% for Qualified Institutional Buyers (QIB), 15% for Non-Institutional Investors (NII), and 35% for Retail Individual Investors (RII), according to SEBI regulations.
● Qualified Institutional Buyers (QIB): As per SEBI regulations, 50% of the shares offered through the IPO will be reserved for Qualified Institutional Buyers. These include entities such as banks, mutual funds, and insurance companies.
● Non-Institutional Investors (NII): 15% of the shares will be reserved for Non-Institutional Investors. These typically include corporate bodies or individuals investing more than Rs.2 lakhs.
● Retail Individual Investors (RII): The remaining 35% of the shares will be allotted to Retail Individual Investors. These individual investors apply for shares with a total value of less than Rs.2 lakhs.
How to apply for Dr Agarwal’s Health Care IPO?
To apply for the Dr Agarwal’s Health Care Limited IPO through Alice Blue, follow these steps:
Open a Demat and Trading Account: If you don’t have one already, you must open a Demat and trading account with Alice Blue.
- Check for IPO Details: Once your account is active, you can check for Dr Agarwal’s Health Care Limited IPO details in the IPO section of the Alice Blue platform.
- Place the Bid: Enter the number of shares you wish to buy and place your bid within the IPO’s price band.
- Submit the Application: Confirm all your details and submit your application.
You can apply for Dr Agarwal’s Health Care Limited IPO at Alice Blue in just a few clicks!
Check Allotment Status: After the allotment process, you can check the allotment status to see if you have received any shares.
Please note that the allotment of shares is not guaranteed and will depend on the demand for the IPO.
How do you check Dr Agarwal’s Health Care IPO Allotment Status?
Checking the allotment status of an IPO in Alice Blue is usually straightforward. Please follow these general steps:
- Log in to your Alice Blue Account: You can do this through the Alice Blue website or the trading app.
- Navigate to the Portfolio or IPO Section: This might differ based on the layout of Alice Blue’s platform, but generally, you can find the status of your IPO application under the ‘Portfolio’ or ‘IPO’ section.
- Find the IPO Allotment Status: Look for a sub-section called ‘IPO Allotment Status’ or something similar. This is where you can see the status of the IPOs you have applied for.
- Select the Dr Agarwal’s Health Care Limited IPO: If you have applied for multiple IPOs, there might be a dropdown menu or a list where you can select the IPO you are interested in. Select the Dr Agarwal’s Health Care Limited IPO.
- Check the Status: The status of your application should be displayed here. If the shares have been allocated to you, it would be mentioned here.
If you face any issues, we request you reach out to our customer support team at Alice Blue for detailed assistance.
Apart from Alice Blue, there are other ways to check the allotment status of the Dr Agarwal’s Health Care Limited IPO:
● Registrar’s Website: Visit the website of KFin Technologies Limited, the registrar of Dr Agarwal’s Health Care Limited IPO. On the homepage, look for the ‘IPO Allotment Status’ option. You must enter your PAN, application, or Demat account number to check your allotment status. Click on the ‘Submit’ button to view your IPO allotment status.
● BSE NSE: You can also check the allotment status on the official websites of the Bombay Stock Exchange (BSE) National Stock Exchange (NSE). You would need your application number and PAN to check the status.
Please note that the allotment status will only be available after completing the allotment process, a few days after the IPO window closes.
Dr Agarwal’s Health Care Ltd IPO Offer Registrar
The registrar for Dr Agarwal’s Health Care Limited IPO is KFin Technologies Limited. They are responsible for ensuring the IPO allotment and refund processes are carried out smoothly.
Contact information for the registrar:
KFin Technologies Limited Selenium,
Tower-B, Plot No. 31 and 32 Financial
District Nanakramguda, Serilingampally
Hyderabad 500 032 Telangana, India
Tel: +91 40 6716 2222
E-mail: [email protected]
Website: www.kfintech.com
Dr Agarwal’s Health Care IPO – FAQs
The allotment date of Dr Agarwal’s Health Care is yet to be announced.
The price band of the issue is yet to be announced.
The offer size of Dr Agarwal’s Health Care Limited is yet to be announced, consisting of a fresh issue of shares worth INR 300 crores and an offer to sell 6.96 existing shares. The company aims to repay borrowings and utilise funds for corporate purposes.
The listing date of Dr Agarwal’s Health Care is yet to be announced.
Dr Agarwal’s Health Care is getting listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE).
The open and close dates of Dr Agarwal’s Health Care Limited are yet to be announced.
To apply for Dr Agarwal’s Health Care Limited IPO through Alice Blue, open a Demat and Trading account, check IPO details, place your bid within the price band, submit the application, and track allotment status. Allotment depends on IPO demand.
The Book Runners for Dr Agarwal’s Health Care are Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Private Limited, Jefferies India Private Limited and Motilal Oswal Investment Advisors Limited.